Biomarker Assays in PCa Management

In this latest of a series of Ask the Experts features on prostate cancer, Renal & Urology News presents separate interviews with two prominent researchers, Stacy Loeb, MD, and R. Jeffrey Karnes, MD, who discuss the role of biomarker assays in prostate cancer detection and management.

Many Elderly May Forgo Neph Care

Referrals to nephrologists may not be warranted for many elderly patients with chronic kidney disease (CKD), who may be managed safely in the primary care setting, British researchers concluded based on a study of CKD patients aged 80 years and older.

Gout Patient Hospitalizations Soar

All-cause hospitalizations among patients with gout in the United States have increased by 410% from 1993 to 2014, a rate much higher than in the US population as a whole, according to a new study presented at the 2017 Annual European Congress of Rheumatology in Madrid.

What Not to Eat After Nephrectomy

In the past, doctors may have reassured kidney donors that they are not at higher risk of ESRD. Today, it would be naïve for physicians to believe that patients with a solitary kidney after nephrectomy do not have a serious condition and do not need dietary advice or diet and lifestyle modification.

Surgery, Combined Modality Similar for MIBC ...

Among muscle-invasive bladder cancer (MIBC) patients without distant metastases, no survival advantages emerged for radical cystectomy (RC) versus combined modality treatment (CMT) in a recent meta-analysis of studies published in the International Journal of Radiation Oncology Biology Physics.

MRI Accuracy for PCa Challenged

Multiparametric magnetic resonance imaging (mpMRI) frequently misses clinically significant prostate tumors outside index lesions, according to study findings presented at the American Urological Association's 2017 annual meeting.

Low-PSA, High-Grade PCa Especially Lethal

Patients with Gleason 8 to 10 prostate cancer (PCa) and PSA values of 2.5 ng/mL or less may harbor hormone-resistant disease that is more lethal than other forms of non-metastatic, node-negative prostate cancers, investigators reported at the American Society of Clinical Oncology (ASCO) Annual Meeting.

Divest Your Practice?

Not surprisingly, as payment models shift, and physicians face lower reimbursements amid growing expenses, many have at least considered — if not seriously contemplated — divesting their practices.

First-Line Abiraterone-ADT New Standard of Care?

Adding abiraterone to androgen-deprivation therapy (ADT) as first-line treatment for advanced or high-risk prostate cancer (PCa) improves survival and delays disease progression compared with ADT alone, according to new studies presented at ASCO's 2017 Annual Meeting.

Stones Linked to HbA1c Levels

Study findings presented at the American Urological Association 2017 annual meeting may explain the known associations between both obesity and diabetes and the formation of kidney stones.

AUA 2017 Coverage

Renal & Urology News is on site at the American Urological Association's 2017 meeting in Boston. Check out our extensive daily coverage for the latest clinical updates in urology.

American Transplant Congress Coverage

Check out the latest research and insights from the 2017 American Transplant Congress.

Looking for a Job?

Access our job board to view over 1,000 job openings throughout the US.

RUN Social Media Survey

Tell us about your social media habits for a chance to win a free gift card.


Sign Up for Free e-newsletters